Article
Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
Cancer medicine - 1 Sept 2022
Xu Qiang, Cao Dedong, Fang Bin, Yan Siqi, Hu Yu, Guo Tao
Abstract excerpt
BACKGROUND: The immune response in the bone marrow microenvironment has implications for progression and prognosis in acute myeloid leukemia (AML). However, few immune-related biomarkers for AML prognosis and immunotherapy response have been identified. We aimed to establish a predictive gene signature and to explore the determinants of prognosis in AML. METHODS: Immune-related genes with clinical significance...
Topics
Join the communities discussing this publication.
